Invesco Ltd. 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 1:51 pm Sale | 2024-12-31 | 13G | ADMA Biologics, Inc. ADMA | Invesco Ltd. IVZ | 11,296,255 4.800% | -1,323,514 (-10.49%) | Filing |
| 2024-11-08 09:21 am Purchase | 2024-11-08 | 13G | ADMA Biologics, Inc. ADMA | Invesco Ltd. IVZ | 12,619,769 5.500% | 12,619,769 (New Position) | Filing |